| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.14 | 0.05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.057 | 0.05 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.06 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.07 |